A Real-time Quality Control System of Magnetic-controlled Capsule Gastroscopy
NCT ID: NCT04954677
Last Updated: 2025-01-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
194 participants
INTERVENTIONAL
2021-08-27
2022-08-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Computer Assisted Quality-monitoring for Magnet-controlled Capsule Endoscopy: a Prospective Case-control Study.
NCT04278196
Real-Time Identification System of Magnetically Controlled Capsule Endoscopy Using Artificial Intelligence
NCT04203264
Prospective Multicenter Study of Artificial Intelligence-assisted Quality Evaluation System for Colonoscopy
NCT04610177
Efficacy of Artificial Intelligence-assisted Colonic Polyp Detection System
NCT05941689
Gastrointestinal Endoscopy Artificial Intelligence Cloud Platform in Gastrointestinal Endoscopy Screening
NCT05435872
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SCREENING
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Participates being subjected to capsule endoscopy (AI-box assistant)
In this group ,Participates will be subjected to magnetically controlled capsule gastroscopy with AI-box assistant.
AI-box
Automatic quality-control system(AI-box)could real-time measure endoscopic inspection completeness, evaluate gastric cleanliness.
Participates being subjected to capsule endoscopy
In this group ,Participates will be subjected to magnetically controlled capsule gastroscopy without AI-box assistant.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
AI-box
Automatic quality-control system(AI-box)could real-time measure endoscopic inspection completeness, evaluate gastric cleanliness.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with astrointestinal bleeding or ulcers, or prior gastrointestinal bleeding or ulcers within the last 24 months;
* Patients with esophageal and gastric tumor diseases that are undergoing active surgical treatment;
* Contraindications to the MCE test, including suspected or known gastrointestinal obstruction, stenosis, fistula, diverticula, etc; presence of gastrointestinal obstruction symptoms such as pain or dysphagia;
* Prior gastrointestinal tract or abdominal surgery other than simple procedures which would not change the gastrointestinal tract anatomy, such as polyp removal, cholecystectomy or appendectomy;
* Inoperative conditions or refusal to undergo abdominal surgery if required (ie, if the capsule will not pass and cannot be removed by endoscopy);
* A cardiac pacemaker is installed in the body, except when the pacemaker is a new MRE-compatible product;
* Electronic devices such as cochlear implant, magnetic metal drug infusion pump, nerve stimulator and magnetic metal foreign body are implanted in vivo;
* Planned MRI examination before capsule endoscopy discharge;
* Pregnant women;
* Patients with deglutition disorders or gastric emptizing disorders.
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ancon Technologies Ltd
INDUSTRY
Shandong Provincial Hospital
OTHER_GOV
Binzhou Medical University
OTHER
Shandong University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yanqing Li
Vice President of Qilu Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yanqing Li, PhD
Role: STUDY_CHAIR
Qilu Hospital of Shandong University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Qilu Hospital of Shandong University
Jinan, Shandong, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-SDU-QILU-087
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.